Intervention: Bispecific antibody for PD-L1 and VEGF-A
Found 14 matching trials
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
PHASE1
This first-in-human (FIH) study for BNT116 aims to establish the safety pro...
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE1
This is a multi-site, open-label, dose-finding study, consisting of Parts 1...
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
PHASE2
This is a Phase II, multisite, open-label study consisting of two parts in ...
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
PHASE1
This randomized, multi-site, three-part study will test a new treatment cal...